HCC1954 Cells

Categories: Breast cancer cell lines Description: The HCC1954 cell line is derived from the primary ductal carcinoma of a human adult breast cancer patient. This cell line is prominently used in breast cancer research, especially for investigating the genetic and molecular characteristics of HER2-positive (HER2+) and triple-negative breast cancers. HCC1954 cells are HER2-overexpressing and possess mutations in the PIK3CA gene, making them a valuable model for studying the signaling pathways involved in cancer progression and the development of targeted therapies. HCC1954 cells exhibit an epithelial morphology and are known for their aggressive growth characteristics both in vitro and in vivo. They express markers associated with aggressive breast cancer phenotypes, including HER2/neu, but lack expression of estrogen receptor (ER) and progesterone receptor (PR), classifying them as triple-negative breast cancer cells. This cell line is extensively used to evaluate the efficacy and mechanisms of action of HER2-targeted therapies, such as trastuzumab, as well as novel PI3K inhibitors. Additionally, HCC1954 cells are employed in research focused on identifying biomarkers for drug resistance and exploring combination treatment strategies to enhance therapeutic outcomes. Their relevance in understanding the biology of aggressive breast cancer and in the development of effective treatments highlights the significance of the HCC1954 cell line in oncological research. Organism: Human Tissue: Breast Disease: Carcinoma Synonyms: HCC-1954, Hamon Cancer Center 1954 Age: 61 years Gender: Female Ethnicity: East Indian Morphology: Epithelial Growth Properties: Adherent Citation: HCC1954 (Cytion catalog number 305268) Biosafety Level: 1 Ncbi_ Taxid: 9606.0 Cellosaurus Accession: CVCL_1259 Receptors Expressed: Estrogen receptor -, progesteron receptor - Protein Expression: epithelial glycoprotein 2 (EGP2), cytokeratin 19 Oncogenes: her2/neu+ (overexpressed) Mutational Profile: Mutation: PIK3CA, p.His1047Arg (c.3140A>G), Mutation: TP53, p.Tyr163Cys (c.488A>G), Gene fusion: CLTC + VMP1 = CLTC-VMP1 Culture Medium: RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) Supplements: Supplement the medium with 10% FBS, add 2.5 g/L glucose, 10 mM HEPES and 1mM sodium pyruvate Dissociation Reagent: Accutase Subculturing: Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. Fluid Renewal: 2 to 3 times per week Freeze Medium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Thawing And Culturing Cells: Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks, for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes. Sterility: Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. Safety Precautions: When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments. Warranty: We stand by the promise of delivering products with high cell viability and robust culture performance. To achieve the best results, please make sure you follow the storage and culture instructions detailed in the product information sheet closely. Your adherence to these guidelines is key to success. Subject To Material Transfer Agreements: If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement. Required Product 1: 820700a Required Product 3: 860015.0 Required Product 4: 830100.0